Venus Remedies has been granted patent by European Patent Office (EPO) for its research drug “ACHNIL” a once a day painkiller injection. This patent grant will be in force till 2025 in the member countries of EPO which will further reinforce the market position of the company in the major economies such as Germany, UK, France, Spain, Sweden, Italy and Switzerland.
Earlier the same formulation was granted by the Indian patent Office. This is the second European patent success for the company after Sulbactomax. This novel formulation based on NDDS (Novel Drug Delivery System) technology is going to fillip the gap of long standing demand for better pain management therapy.
ACHNIL starts its action instantly by giving immediate relief from acute pain and is effective for the next 24 hours as against the conventional daily dose of three injections of diclofenac given every 8 hours.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.50 |
Dr. Reddys Lab | 5784.50 |
Cipla | 1451.25 |
Zydus Lifesciences | 1001.15 |
Lupin | 1587.90 |
View more.. |